×

23andMe back after FDA pause

8:48 AM ET Mon, 7 Dec 2015

Biotech company 23andMe offered low-cost personalized DNA analysis to help customers make informed health care decisions. CNBC's Julia Boorstin reports the company is back after the FDA put the tests on pause in 2013.